David Croteau Selected Research

IL13-PE38

1/2011	Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.
8/2010	Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
11/2007	Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
7/2007	Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.
3/2007	Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
2/2007	Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
4/2006	Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
2/2005	Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Croteau Research Topics

Disease

10	Neoplasms (Cancer) 01/2011 - 02/2005
8	Glioma (Gliomas) 11/2007 - 02/2005
2	HIV Infections (HIV Infection) 01/2018 - 03/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2011 - 08/2010
2	Brain Neoplasms (Brain Tumor) 11/2010 - 06/2006
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2022
1	Hyperkinesis 05/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Multiple Sclerosis 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	Progressive Multifocal Leukoencephalopathy 01/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Acalculous Cholecystitis 01/2018
1	Relapsing-Remitting Multiple Sclerosis 01/2018
1	Critical Illness (Critically Ill) 01/2018
1	Cytokine Release Syndrome 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2016
1	Coinfection 04/2016
1	Neoplasm Metastasis (Metastasis) 11/2010
1	Aphasia (Dysphasia) 11/2007
1	Confusion (Bewilderment) 11/2007
1	Gaucher Disease (Gaucher's Disease) 07/2007

Drug/Important Bio-Agent (IBA)

8	IL13-PE38IBA 01/2011 - 02/2005
7	Cytotoxins (Cytolysins)IBA 11/2007 - 02/2005
5	Pharmaceutical PreparationsIBA 05/2022 - 04/2006
4	Interleukin-13IBA 11/2007 - 02/2005
3	ExotoxinsIBA 11/2007 - 02/2005
3	Human Serum Albumin FDA LinkGeneric 07/2007 - 02/2007
2	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 01/2011 - 08/2010
2	Temozolomide (Temodar)FDA LinkGeneric 11/2010 - 11/2007
1	Methylphenidate (Ritalin)FDA LinkGeneric 05/2022
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 05/2022
1	Amphetamine (Amfetamine)FDA LinkGeneric 05/2022
1	Antipsychotic Agents (Antipsychotics)IBA 05/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021
1	Dimethyl FumarateIBA 01/2021
1	erenumabIBA 01/2021
1	Eszopiclone (Lunesta)FDA Link 01/2020
1	zaleplon (Sonata)FDA LinkGeneric 01/2020
1	Zolpidem (Ambien)FDA LinkGeneric 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2018
1	RNA (Ribonucleic Acid)IBA 04/2016
1	Darunavir (Prezista)FDA Link 03/2013
1	Carmustine (FIVB)FDA Link 08/2010
1	IodineIBA 07/2007
1	Pentetic Acid (DTPA)FDA LinkGeneric 07/2007
1	AcidsIBA 07/2007
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 06/2006
1	CytokinesIBA 06/2006
1	Pseudomonas aeruginosa Exotoxin AIBA 04/2006
1	InterleukinsIBA 02/2005
1	Biological ProductsIBA 02/2005
1	Biomarkers (Surrogate Marker)IBA 02/2005

Therapy/Procedure

6	Catheters 01/2011 - 02/2005
2	Therapeutics 01/2018 - 06/2006
2	Radiotherapy 11/2010 - 11/2007
1	Conservative Treatment 01/2018
1	Chemoradiotherapy 11/2007
1	Operative Surgical Procedures 04/2006